Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch
2011/08/18 by P. Anand, Praveen Anand, K. Bley +1 · 34 citations
Medicine · Neuroscience · Immunology and Microbiology · #Pain Mechanisms and Treatments #Ion Channels and Receptors #Toxin Mechanisms and Immunotoxins
paper · pdf · doi:10.1093/bja/aer260
Abstract
Topical capsaicin formulations are used for pain management. Safety and modest efficacy of low-concentration capsaicin formulations, which require repeated daily self-administration, are supported by meta-analyses of numerous studies. A high-concentration capsaicin 8% patch (Qutenza™) was recently approved in the EU and USA. A single 60-min application in patients with neuropathic pain produced effective pain relief for up to 12 weeks. Advantages of the high-concentration capsaicin patch include longer duration of effect, patient compliance, and low risk for systemic effects or drug-drug interactions. The mechanism of action of topical capsaicin has been ascribed to depletion of substance P. However, experimental and clinical studies show that depletion of substance P from nociceptors is only a correlate of capsaicin treatment and has little, if any, causative role in pain relief. Rather, topical capsaicin acts in the skin to attenuate cutaneous hypersensitivity and reduce pain by a process best described as 'defunctionalization' of nociceptor fibres. Defunctionalization is due to a number of effects that include temporary loss of membrane potential, inability to transport neurotrophic factors leading to altered phenotype, and reversible retraction of epidermal and dermal nerve fibre terminals. Peripheral neuropathic hypersensitivity is mediated by diverse mechanisms, including altered expression of the capsaicin receptor TRPV1 or other key ion channels in affected or intact adjacent peripheral nociceptive nerve fibres, aberrant re-innervation, and collateral sprouting, all of which are defunctionalized by topical capsaicin. Evidence suggests that the utility of topical capsaicin may extend beyond painful peripheral neuropathies.
Cited by
- Mechanisms and clinical uses of capsaicin
- Neuropathic Pain: From Mechanisms to Treatment
- Capsaicin treatment reduces nasal hyperreactivity and transient receptor potential cation channel subfamily V, receptor 1 (TRPV1) overexpression in patients with idiopathic rhinitis
- Development of an innervated human skin equivalent to model nociceptive circuitry in vitro
- In vitro activation of the neuro-transduction mechanism in sensitive organotypic human skin model
- Myofascial Pain Syndrome: An Update on Clinical Characteristics, Etiopathogenesis, Diagnosis, and Treatment
- Historia y memoria: reflexiones desde la investigación
- A comprehensive review of nanotechnology based drug delivery systems for osteoarthritis treatment
- Nano-sized carriers for capsaicinoids with topic analgesic and anti-inflammatory effects
- Pungency [wikipedia]
- Neuroplasticity of sensory and sympathetic nerve fibers in a mouse model of a painful arthritic joint. [europepmc]
- Deconstructing the neuropathic pain phenotype to reveal neural mechanisms. [europepmc]
- Topical capsaicin (low concentration) for chronic neuropathic pain in adults. [europepmc]
- Research designs for proof-of-concept chronic pain clinical trials: IMMPACT recommendations. [europepmc]
- TRP ion channels in thermosensation, thermoregulation and metabolism. [europepmc]
- Capsaicin, Nociception and Pain. [europepmc]
- Capsaicin: Current Understanding of Its Mechanisms and Therapy of Pain and Other Pre-Clinical and Clinical Uses. [europepmc]
- Harnessing the Therapeutic Potential of Capsaicin and Its Analogues in Pain and Other Diseases. [europepmc]
- TRPV1: A Target for Rational Drug Design. [europepmc]
- Use of Capsaicin to Treat Pain: Mechanistic and Therapeutic Considerations. [europepmc]
- Capsaicin 8% patch repeat treatment plus standard of care (SOC) versus SOC alone in painful diabetic peripheral neuropathy: a randomised, 52-week, open-label, safety study. [europepmc]
- Topical capsaicin (high concentration) for chronic neuropathic pain in adults. [europepmc]
- Targeting dorsal root ganglia and primary sensory neurons for the treatment of chronic pain. [europepmc]
- Topical analgesics for acute and chronic pain in adults - an overview of Cochrane Reviews. [europepmc]
- Control of mechanical pain hypersensitivity in mice through ligand-targeted photoablation of TrkB-positive sensory neurons. [europepmc]
- Intra-articular treatment options for knee osteoarthritis. [europepmc]
- Randomized, Double-Blind, Placebo-Controlled Trial of Intraarticular Trans-Capsaicin for Pain Associated With Osteoarthritis of the Knee. [europepmc]
- Painful and Painless Diabetic Neuropathies: What Is the Difference? [europepmc]
- Diverse TRPV1 responses to cannabinoids. [europepmc]
- A Comprehensive Algorithm for Management of Neuropathic Pain. [europepmc]
- Human Dorsal Root Ganglia. [europepmc]
- Rational treatment of chemotherapy-induced peripheral neuropathy with capsaicin 8% patch: from pain relief towards disease modification. [europepmc]
- Fight fire with fire: Neurobiology of capsaicin-induced analgesia for chronic pain. [europepmc]
- Chemotherapy-induced peripheral neuropathy (CIPN): current therapies and topical treatment option with high-concentration capsaicin. [europepmc]
- Plant-Derivatives Small Molecules with Antibacterial Activity. [europepmc]
Related